SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-034504
Filing Date
2023-03-20
Accepted
2023-03-20 16:52:54
Documents
13
Period of Report
2023-03-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm239970d1_8k.htm   iXBRL 8-K 32836
2 EXHIBIT 99.1 tm239970d1_ex99-1.htm EX-99.1 10531
  Complete submission text file 0001104659-23-034504.txt   225302

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA akya-20230320.xsd EX-101.SCH 3034
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE akya-20230320_lab.xml EX-101.LAB 34477
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE akya-20230320_pre.xml EX-101.PRE 22596
7 EXTRACTED XBRL INSTANCE DOCUMENT tm239970d1_8k_htm.xml XML 3718
Mailing Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762
Business Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762 855.896.8401
Akoya Biosciences, Inc. (Filer) CIK: 0001711933 (see all company filings)

IRS No.: 475586242 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40344 | Film No.: 23746885
SIC: 3826 Laboratory Analytical Instruments